Debra L. Barton

12.3k total citations · 5 hit papers
163 papers, 8.4k citations indexed

About

Debra L. Barton is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Debra L. Barton has authored 163 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 48 papers in Endocrinology, Diabetes and Metabolism and 32 papers in Genetics. Recurrent topics in Debra L. Barton's work include Menopause: Health Impacts and Treatments (40 papers), Cancer survivorship and care (37 papers) and Cancer Treatment and Pharmacology (33 papers). Debra L. Barton is often cited by papers focused on Menopause: Health Impacts and Treatments (40 papers), Cancer survivorship and care (37 papers) and Cancer Treatment and Pharmacology (33 papers). Debra L. Barton collaborates with scholars based in United States, Vietnam and Canada. Debra L. Barton's co-authors include Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, Beth LaVasseur, Sherry L. Wolf, Deirdre R. Pachman, Lisa A. Kottschade, Bradley J. Christensen, Axel Grothey and Shaker R. Dakhil and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Debra L. Barton

160 papers receiving 8.0k citations

Hit Papers

Venlafaxine in management of hot flashes in survivors of ... 2000 2026 2008 2017 2000 2016 2022 2022 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
    2000 539 citations Charles L. Loprinzi, John W. Kugler et al. The Lancet profile →
  2. Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
    2016 446 citations Debra L. Barton et al. Journal of Clinical Oncology profile →
  3. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
    2022 139 citations Debra L. Barton, Thomas W. LeBlanc et al. Journal of Clinical Oncology profile →
  4. Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
    2022 109 citations Judith A. Paice, Kari Bohlke et al. Journal of Clinical Oncology profile →
  5. Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
    2024 52 citations Julienne E. Bower, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra L. Barton United States 49 3.5k 2.4k 1.9k 1.4k 1.2k 163 8.4k
Shelley S. Tworoger United States 62 3.8k 1.1× 1.7k 0.7× 2.0k 1.0× 881 0.6× 1.7k 1.3× 340 13.4k
Annlia Paganini‐Hill United States 55 2.3k 0.7× 2.8k 1.1× 3.2k 1.6× 1.3k 1.0× 1.4k 1.2× 195 11.6k
Margery Gass United States 46 2.1k 0.6× 5.6k 2.3× 4.4k 2.3× 682 0.5× 2.1k 1.7× 110 12.4k
Susan L. Hendrix United States 44 2.1k 0.6× 3.6k 1.5× 3.9k 2.0× 552 0.4× 1.4k 1.2× 97 10.1k
Jane Morley Kotchen United States 36 769 0.2× 2.5k 1.0× 1.8k 0.9× 611 0.4× 870 0.7× 87 6.8k
Kala Visvanathan United States 43 2.2k 0.6× 355 0.1× 1.1k 0.6× 833 0.6× 670 0.5× 191 7.8k
Aaron K. Aragaki United States 44 2.4k 0.7× 2.9k 1.2× 3.1k 1.6× 666 0.5× 1.3k 1.1× 144 10.3k
Masahiro Akishita Japan 61 465 0.1× 2.1k 0.9× 793 0.4× 980 0.7× 437 0.4× 337 11.6k
Mats Hammar Sweden 42 477 0.1× 2.0k 0.8× 1.1k 0.6× 270 0.2× 813 0.7× 184 5.2k
Wendy Y. Chen United States 48 3.9k 1.1× 442 0.2× 1.4k 0.7× 662 0.5× 1.1k 0.9× 128 7.0k

Countries citing papers authored by Debra L. Barton

Since Specialization
Citations

This map shows the geographic impact of Debra L. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra L. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra L. Barton more than expected).

Fields of papers citing papers by Debra L. Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra L. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra L. Barton. The network helps show where Debra L. Barton may publish in the future.

Co-authorship network of co-authors of Debra L. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Debra L. Barton. A scholar is included among the top collaborators of Debra L. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra L. Barton. Debra L. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bower, Julienne E., Christina Lacchetti, Yesne Alici, et al.. (2024). Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update. Journal of Clinical Oncology. 42(20). 2456–2487. 52 indexed citations breakdown →
2.
Quinn, Martha, Debra L. Barton, Marita G. Titler, et al.. (2023). A descriptive study of policy and system-level interventions to address cancer survivorship issues across six United States health systems. Journal of Cancer Survivorship. 18(6). 2022–2032. 1 indexed citations
3.
Hoeve, Elizabeth S. Ver, Melissa A. Simon, Sanja Percac‐Lima, et al.. (2022). Implementing patient navigation programs: Considerations and lessons learned from the Alliance to Advance Patient‐Centered Cancer Care. Cancer. 128(14). 2806–2816. 10 indexed citations
4.
Paice, Judith A., Kari Bohlke, Debra L. Barton, et al.. (2022). Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. Journal of Clinical Oncology. 41(4). 914–930. 109 indexed citations breakdown →
5.
Barton, Debra L., Stephanie L. Pugh, Patricia A. Ganz, et al.. (2021). Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004. Journal of Clinical Oncology. 40(4). 324–334. 12 indexed citations
6.
7.
8.
Baydoun, Mohamad & Debra L. Barton. (2018). Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review. Bone Marrow Transplantation. 53(5). 556–564. 10 indexed citations
9.
Elkins, Gary, et al.. (2016). Developing a Hypnotic Relaxation Intervention to Improve Body Image: A Feasibility Study. Oncology nursing forum. 43(6). E233–E241. 6 indexed citations
10.
Pachman, Deirdre R., Charles L. Loprinzi, Paul J. Novotny, et al.. (2013). Sternal skin conductance. Menopause The Journal of The North American Menopause Society. 20(11). 1164–1168. 6 indexed citations
11.
Barton, Debra L., Kelli N. Burger, Paul J. Novotny, et al.. (2012). The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Supportive Care in Cancer. 21(4). 1185–1192. 43 indexed citations
12.
13.
Loprinzi, Charles L., Debra L. Barton, Kendrith M. Rowland, et al.. (2009). A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Annals of Oncology. 20(3). 542–549. 48 indexed citations
14.
Loprinzi, Charles L., Debra L. Barton, Jeff A. Sloan, et al.. (2008). Mayo Clinic and North Central Cancer Treatment Group hot flash studies. Menopause The Journal of The North American Menopause Society. 15(4). 655–660. 48 indexed citations
15.
Barton, Debra L., Charles L. Loprinzi, Philip J. Atherton, et al.. (2007). Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. PubMed. 4(4). 219–224. 7 indexed citations
16.
Loprinzi, Charles L., Ralph Levitt, Debra L. Barton, et al.. (2006). Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7. Journal of Clinical Oncology. 24(9). 1409–1414. 86 indexed citations
17.
Loprinzi, Charles L., John W. Kugler, James A. Mailliard, et al.. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. The Lancet. 356(9247). 2059–2063. 539 indexed citations breakdown →
18.
Barton, Debra L., Charles L. Loprinzi, Susan K. Quella, et al.. (1998). Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.. Journal of Clinical Oncology. 16(2). 495–500. 288 indexed citations
19.
Wilwerding, Mary B., Charles L. Loprinzi, James A. Mailliard, et al.. (1995). A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Supportive Care in Cancer. 3(2). 135–138. 88 indexed citations
20.
Kristal, Mark B., et al.. (1990). Amniotic Fluid Ingestion Enhances \nOpioid-Mediated But Not \nNonopioid-Mediated Analgesia. CogPrints (University of Southampton). 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shelley S. Tworoger Breakdown of academic impact, for papers by Annlia Paganini‐Hill Breakdown of academic impact, for papers by Margery Gass Breakdown of academic impact, for papers by Susan L. Hendrix Breakdown of academic impact, for papers by Jane Morley Kotchen Breakdown of academic impact, for papers by Kala Visvanathan Breakdown of academic impact, for papers by Aaron K. Aragaki Breakdown of academic impact, for papers by Masahiro Akishita Breakdown of academic impact, for papers by Mats Hammar Breakdown of academic impact, for papers by Wendy Y. Chen
Rankless by CCL
2026